Conavi Medical Corp.
CNVIF
Rang in aandelen
#33304
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Aandeelprijs
$0.088
Marktkapitalisatie
$7.51M
Verandering (1 dag)
-11.65%
Verandering (1 jaar)
-89.24%
Land
CA
Handel Conavi Medical Corp. (CNVIF)
Categorie
Healthcare
Winst voor Conavi Medical Corp. (CNVIF)
Winst in Jun 2024 TTM: $-5.11M
Volgens de meest recente financiële verslagen van Conavi Medical Corp. bedraagt de huidige winst van het bedrijf $-5.11M. In 2022 behaalde het bedrijf een winst van $-40.91M, een daling ten opzichte van de winst van 2021, die $-14.67M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Conavi Medical Corp. van 2016 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-5.11M | -171.87% |
| 2023 | $7.10M | -117.37% |
| 2022 | $-40.91M | 178.84% |
| 2021 | $-14.67M | -42.38% |
| 2020 | $-25.46M | -40.62% |
| 2019 | $-42.88M | 99.59% |
| 2018 | $-21.48M | -38.25% |
| 2017 | $-34.79M | 51.00% |
| 2016 | $-23.04M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | -147,201.25% |
US
|
|
| $5.56B | -109,050.11% |
IE
|
|
| $5.15B | -100,922.42% |
US
|
|
| $3.86B | -75,716.82% |
US
|
|
| - | - |
DE
|
